We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

34 hedge funds and large institutions have $5.83M invested in Windtree Therapeutics Inc in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

16,700% more call options, than puts

Call options by funds: $336K | Put options by funds: $2K

36% less funds holding

Funds holding: 53 → 34 (-19)

48% less capital invested

Capital invested by funds: $11.2M → $5.83M (-$5.39M)

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

90% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 21

Holders
34
Holders Change
-19
Holders Change %
-35.85%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
20
Closed
21
Calls
$336K
Puts
$2K
Net Calls
+$334K
Net Calls Change
-$7.16M

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$90.4K
2
RFS
Rockefeller Financial Services
New York
+$59.4K
3
Renaissance Technologies
Renaissance Technologies
New York
+$52.5K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$30.2K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$27.6K

Top Sellers

Rank Fund Capital Flow
1
LCM
Laurion Capital Management
New York
-$278K
2
Millennium Management
Millennium Management
New York
-$213K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$153K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$31K
5
SC
Searle & Co
Connecticut
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$1.3M -$2 -1 -0%
SM
2
Sabby Management
Florida
$934K +$90.4K +42,099 +8%
DCM
3
DAFNA Capital Management
California
$891K -$2 -1 -0%
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$760K +$27.6K +12,858 +3%
BBA
5
Baker Bros. Advisors
New York
$426K -$4 -2 -0%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$408K +$2.27K +1,056 +0.4%
Vanguard Group
7
Vanguard Group
Pennsylvania
$324K +$30.2K +14,068 +8%
BIT
8
BlackRock Institutional Trust
California
$317K -$9 -4 -0%
Millennium Management
9
Millennium Management
New York
$225K -$213K -99,025 -42%
Deutsche Bank
10
Deutsche Bank
Germany
$74K +$2.13K +991 +2%
RFS
11
Rockefeller Financial Services
New York
$46K +$59.4K +27,658 New
Renaissance Technologies
12
Renaissance Technologies
New York
$43K +$52.5K +24,433 +2,327%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$20K -$2 -1 -0%
WS
14
Wedbush Securities
California
$18K -$4 -2 -0%
Walleye Trading
15
Walleye Trading
New York
$9K +$11.2K +5,200 New
UBS Group
16
UBS Group
Switzerland
$8K -$6.61K -3,078 -40%
Morgan Stanley
17
Morgan Stanley
New York
$7K +$301 +140 +3%
Group One Trading
18
Group One Trading
Illinois
$5K -$4.99K -2,324 -45%
BA
19
BlackRock Advisors
Delaware
$5K – – –
BAM
20
Brave Asset Management
New Jersey
$4K -$6 -3 -0.1%
TRCT
21
Tower Research Capital (TRC)
New York
$4K +$4.75K +2,211 +773%
BFA
22
BlackRock Fund Advisors
California
$3K +$661 +308 +21%
Wells Fargo
23
Wells Fargo
California
$1K -$32 -15 -2%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$89 -$54 -25 -0%
MPWT
25
MassMutual Private Wealth & Trust
Connecticut
$33 – – –
1
2 3

WINT Hedge Fund Activity: Q1 2016 in Review

34 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q1 2016, worth a combined $5.83M — down 48% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of WINT and 2 opened new positions — a net loss of 19 holders — while 20 trimmed existing stakes and 9 added.

The largest buyer was Sabby Management, adding an estimated $90.4K. The largest seller was Laurion Capital Management, exiting entirely with an estimated $278K sold.

  • 34 institutional investors held Windtree Therapeutics Inc (WINT) as of Q1 2016, down from 53 in Q4 2015.
  • Funds reported $5.83M of Windtree Therapeutics Inc stock for Q1 2016, down 48% quarter-over-quarter.
  • 2 funds opened new Windtree Therapeutics Inc positions in Q1 2016 and 21 closed out, a net change of -19 holders.
  • The largest Windtree Therapeutics Inc buyer in Q1 2016 was Sabby Management, an estimated $90.4K added.
  • The largest Windtree Therapeutics Inc seller in Q1 2016 was Laurion Capital Management, an estimated $278K sold.

Based on aggregated 13F filings for Q1 2016.